Cargando…

Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study

BACKGROUND: Sclerostin, an antagonist of the Wingless-type mouse mammary tumor virus integration site (Wnt) pathway that regulates bone metabolism, is a potential contributor of chronic kidney disease (CKD)–mineral and bone disorder (MBD), which has various forms of presentation, from osteoporosis t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuo, Te-Hui, Lin, Wei-Hung, Chao, Jo-Yen, Wu, An-Bang, Tseng, Chin-Chung, Chang, Yu-Tzu, Liou, Hung-Hsiang, Wang, Ming-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637583/ https://www.ncbi.nlm.nih.gov/pubmed/31315601 http://dx.doi.org/10.1186/s12882-019-1452-5

Ejemplares similares

The serum sclerostin level is positively associated with the aortic augmentation index in patients on peritoneal dialysis
por: Lin, Lin, et al.
Publicado: (2019)

Serum Sclerostin Level Is Negatively Associated with Bone Mineral Density in Hemodialysis Patients
por: Lu, Jing-Wun, et al.
Publicado: (2022)

Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients
por: Chang, Yu-Chi, et al.
Publicado: (2018)

Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study
por: Hsu, Bang-Gee, et al.
Publicado: (2016)

The Correlation between Serum Sclerostin Level and Arterial Stiffness in Peritoneal Dialysis Patients
por: Liu, Fang, et al.
Publicado: (2022)

Retracted: The Correlation between Serum Sclerostin Level and Arterial Stiffness in Peritoneal Dialysis Patients
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Inverse relationship of bone mineral density and serum level of N-terminal pro-B-type natriuretic peptide in peritoneal dialysis patients
por: Wang, Chih-Hsien, et al.
Publicado: (2016)

Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients
por: Wu, Chun-Feng, et al.
Publicado: (2020)

Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus
por: Ross, Ryan D., et al.
Publicado: (2020)

Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study
por: Chiu, Ping-Fang, et al.
Publicado: (2016)

Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients
por: Lee, Wen-Teng, et al.
Publicado: (2023)

The relationship between serum pro-B type natriuretic peptide level and bone mineral density in peritoneal dialysis patients
por: Doğan, Ayse Gulsen, et al.
Publicado: (2023)

The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage
por: Lee, Yi-Che, et al.
Publicado: (2019)

A Matrix Metalloproteinase-2-Based Nomogram to Assess the Risk of Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients
por: Chou, Che-Yi, et al.
Publicado: (2021)

Exercise Alleviates Osteoporosis in Rats with Mild Chronic Kidney Disease by Decreasing Sclerostin Production
por: Liao, Hung-Wei, et al.
Publicado: (2019)

Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
por: Liao, Chia-Te, et al.
Publicado: (2021)

Impact of Environmental Particulate Matter and Peritoneal Dialysis-related Infection in Patients Undergoing Peritoneal Dialysis
por: Huang, Wen-Hung, et al.
Publicado: (2014)

Determinants of bone mineral density in patients on haemodialysis or peritoneal dialysis – a cross-sectional, longitudinal study
por: Nybo, Mads, et al.
Publicado: (2013)

High Levels of Physical Activity May Promote a Reduction in Bone Mineral Density in Peritoneal Dialysis
por: Raimundo, Armando, et al.
Publicado: (2020)

Home-based exercise and bone mineral density in peritoneal dialysis patients: a randomized pilot study
por: Watanabe, Kumi, et al.
Publicado: (2021)

Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting
por: Fassio, Angelo, et al.
Publicado: (2022)

Serum Osteopontin Level Is Positively Associated with Aortic Stiffness in Patients with Peritoneal Dialysis
por: Chang, Kai-Hsiang, et al.
Publicado: (2022)

Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease
por: Lin, Yu-Li, et al.
Publicado: (2021)

Novel Application of Magnetite Nanoparticle-Mediated Vitamin D3 Delivery for Peritoneal Dialysis-Related Peritoneal Damage
por: Cheng, Fong-Yu, et al.
Publicado: (2021)

Citrobacter Peritoneal Dialysis Peritonitis: Rare Occurrence with Poor Outcomes
por: Chao, Chia-Ter, et al.
Publicado: (2013)

Associations between the Duration of Dialysis, Endotoxemia, Monocyte Chemoattractant Protein-1, and the Effects of a Short-Dwell Exchange in Patients Requiring Continuous Ambulatory Peritoneal Dialysis
por: Wu, Chia-Lin, et al.
Publicado: (2014)

Author Correction: Aberrant serum parathyroid hormone, calcium, and phosphorus as risk factors for peritonitis in peritoneal dialysis patients
por: Liao, Chia-Te, et al.
Publicado: (2022)

Mendelian Randomization Analysis Reveals a Causal Influence of Circulating Sclerostin Levels on Bone Mineral Density and Fractures
por: Zheng, Jie, et al.
Publicado: (2019)

Association of sclerostin with cardiovascular events and mortality in dialysis patients
por: Zou, Yun, et al.
Publicado: (2020)

Prophylactic Antibiotics for Endoscopy-Associated Peritonitis in Peritoneal Dialysis Patients
por: Wu, Hsin-Hsu, et al.
Publicado: (2013)

Association between blood cadmium levels and malnutrition in peritoneal dialysis
por: Hsu, Ching-Wei, et al.
Publicado: (2014)

Positive Association of Serum Galectin-3 with the Development of Aortic Stiffness of Patients on Peritoneal Dialysis
por: Huang, Po-Yu, et al.
Publicado: (2023)

Acinetobacter Peritoneal Dialysis Peritonitis: A Changing Landscape over Time
por: Chao, Chia-Ter, et al.
Publicado: (2014)

Peritoneal dialysis peritonitis by anaerobic pathogens: a retrospective case series
por: Chao, Chia-Ter, et al.
Publicado: (2013)

Environmental NO(2) Level is Associated with 2-Year Mortality in Patients Undergoing Peritoneal Dialysis
por: Lin, Jui-Hsiang, et al.
Publicado: (2015)

Risk of Serious Falls Between Hemodialysis and Peritoneal Dialysis Patients: A Nationwide Population-based Cohort Study
por: Wang, Hsi-Hao, et al.
Publicado: (2020)

Inverse association of serum osteocalcin and bone mineral density in renal transplant recipients
por: Lin, Wei-Chen, et al.
Publicado: (2022)

Single-centre cross-sectional study on the impact of cumulative erythropoietin on bone mineral density in maintenance dialysis patients
por: Cheng, Chung-Yi, et al.
Publicado: (2022)

Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
por: Peng, Jia, et al.
Publicado: (2021)

Association between the appendicular lean mass index or handgrip strength and bone mineral density in patients undergoing peritoneal dialysis
por: Kang, Seok Hui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c0kejsvk4df6m2kg1g5pd9ja23